Published in J Clin Invest on February 15, 1996
Mechanisms of muscle wasting in chronic kidney disease. Nat Rev Nephrol (2014) 1.21
Down-regulation of hepatic cytochrome p450 in chronic renal failure: role of uremic mediators. Br J Pharmacol (2002) 1.14
Growth hormone axis in chronic kidney disease. Pediatr Nephrol (2007) 1.10
Effects of oral sodium bicarbonate in patients with CKD. Clin J Am Soc Nephrol (2013) 1.06
Effects of serum from patients with chronic renal failure on rat hepatic cytochrome P450. Br J Pharmacol (2005) 1.05
Impaired JAK-STAT signal transduction contributes to growth hormone resistance in chronic uremia. J Clin Invest (2001) 0.98
Signal regulatory protein-α interacts with the insulin receptor contributing to muscle wasting in chronic kidney disease. Kidney Int (2013) 0.98
Metabolic acidosis and the progression of chronic kidney disease. BMC Nephrol (2014) 0.96
The growth hormone-insulin-like growth factor-I axis in chronic kidney disease. Growth Horm IGF Res (2007) 0.95
Nutrition and growth in children with chronic kidney disease. Nat Rev Nephrol (2011) 0.92
Growth hormone resistance in uremia, a role for impaired JAK/STAT signaling. Pediatr Nephrol (2005) 0.91
Treatment of metabolic acidosis in patients with CKD. Am J Kidney Dis (2013) 0.85
Effect of oral anabolic steroid on muscle strength and muscle growth in hemodialysis patients. Clin J Am Soc Nephrol (2012) 0.84
Muscle atrophy in chronic kidney disease results from abnormalities in insulin signaling. J Ren Nutr (2010) 0.84
CKD Stimulates Muscle Protein Loss Via Rho-associated Protein Kinase 1 Activation. J Am Soc Nephrol (2015) 0.84
Downregulation of hepatic acetylation of drugs in chronic renal failure. J Am Soc Nephrol (2008) 0.83
Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients. J Clin Invest (1997) 0.81
Insulin resistance and muscle metabolism in chronic kidney disease. ISRN Endocrinol (2013) 0.79
OPPORTUNITY: a randomized clinical trial of growth hormone on outcome in hemodialysis patients. Clin J Am Soc Nephrol (2008) 0.78
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
A fluorometric method for the estimation of tyrosine in plasma and tissues. J Lab Clin Med (1957) 5.04
The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J Biol Chem (1978) 4.55
Nutritional regulation of the insulin-like growth factors. Endocr Rev (1994) 3.18
Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc Natl Acad Sci U S A (1984) 3.13
The subunit structures of two distinct receptors for insulin-like growth factors I and II and their relationship to the insulin receptor. J Biol Chem (1982) 2.62
Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay. J Clin Invest (1977) 2.46
The nature and regulation of the receptors for insulin-like growth factors. Annu Rev Physiol (1985) 2.19
IRS-1 is a common element in insulin and insulin-like growth factor-I signaling to the phosphatidylinositol 3'-kinase. Endocrinology (1993) 2.07
Mechanisms for defects in muscle protein metabolism in rats with chronic uremia. Influence of metabolic acidosis. J Clin Invest (1987) 1.60
Developmental regulation of the rat insulin-like growth factor I receptor gene. Proc Natl Acad Sci U S A (1989) 1.44
Comparison of protein synthesis and degradation in incubated and perfused muscle. Biochem J (1983) 1.42
IGF-I--stimulated glucose transport in human skeletal muscle and IGF-I resistance in obesity and NIDDM. Diabetes (1990) 1.38
Binding proteins for the insulin-like growth factors: structure, regulation and function. Prog Growth Factor Res (1989) 1.38
Differential expression of alternative 5' untranslated regions in mRNAs encoding rat insulin-like growth factor I. Proc Natl Acad Sci U S A (1987) 1.33
Effect of nutrition on morbidity and mortality in maintenance dialysis patients. Am J Kidney Dis (1994) 1.29
The type I insulin-like growth factor receptor mediates the rapid effects of multiplication-stimulating activity on membrane transport systems in rat soleus muscle. J Biol Chem (1984) 1.10
Pulsatile intravenous growth hormone (GH) infusion to hypophysectomized rats increases insulin-like growth factor I messenger ribonucleic acid in skeletal tissues more effectively than continuous GH infusion. Endocrinology (1988) 1.10
Recombinant human insulin-like growth factor-I accelerates recovery and reduces catabolism in rats with ischemic acute renal failure. J Clin Invest (1993) 1.07
Developmental expression of receptors for insulin, insulin-like growth factor I (IGF-I), and IGF-II in rat skeletal muscle. Endocrinology (1989) 1.06
A novel fetal insulin-like growth factor (IGF) I receptor. Mechanism for increased IGF I- and insulin-stimulated tyrosine kinase activity in fetal muscle. J Biol Chem (1989) 1.02
Regulation of start site usage in the leader exons of the rat insulin-like growth factor-I gene by development, fasting, and diabetes. Mol Endocrinol (1991) 1.01
Components of signaling pathways for insulin and insulin-like growth factor-I in muscle myoblasts and myotubes. Endocrinology (1992) 0.99
Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome). J Clin Endocrinol Metab (1993) 0.96
Insulin resistance in uremia: insulin receptor kinase activity in liver and muscle from chronic uremic rats. Am J Physiol (1988) 0.93
Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uraemia. Pediatr Nephrol (1991) 0.92
Muscle biopsy studies in chronically uremic patients: evidence for malnutrition. Kidney Int Suppl (1983) 0.90
Light microscopic study of striated muscle in uremia. Acta Neuropathol (1980) 0.89
Changes in protein metabolism of ovine primary muscle cultures on treatment with growth hormone, insulin, insulin-like growth factor I or epidermal growth factor. J Endocrinol (1987) 0.87
Protein synthesis and degradation in skeletal muscle of chronically uremic rats. Kidney Int (1986) 0.86
Expression of insulin-like growth factor-1 in uremic rats: growth hormone resistance and nutritional intake. Kidney Int (1993) 0.84
Chronic renal failure is a state of cellular calcium toxicity. Am J Kidney Dis (1993) 0.83
In-vivo regulation of messenger RNA encoding insulin-like growth factor-I (IGF-I) and its receptor by diabetes, insulin and IGF-I in rat muscle. J Endocrinol (1992) 0.82
Impaired metabolic response to recombinant insulin-like growth factor-1 in dialysis patients. Kidney Int (1995) 0.81
The endocrine role of insulin-like growth factor I. Acta Paediatr Scand Suppl (1991) 0.81
Anabolic effects of insulin-like growth factor-I (IGF-I) and an IGF-I variant in normal female rats. J Endocrinol (1993) 0.81
Effect of metabolic acidosis on the expression of insulin-like growth factor and growth hormone receptor. Kidney Int (1993) 0.81
Mechanisms that cause protein and amino acid catabolism in uremia. Am J Kidney Dis (1993) 0.80
Intracellular calcium regulates insulin-like growth factor-I messenger ribonucleic acid levels. Endocrinology (1993) 0.80
The effects of recombinant human growth hormone and intradialytic parenteral nutrition in malnourished hemodialysis patients. Am J Kidney Dis (1993) 0.79
Circulating somatomedin activity and sulfate levels in adults with normal and impaired kidney function. Metabolism (1981) 0.77
Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int (2006) 6.61
Kinetic analysis of lead metabolism in healthy humans. J Clin Invest (1976) 4.12
A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis (2001) 3.45
Lead metabolism in the normal human: stable isotope studies. Science (1973) 2.29
Association among SF36 quality of life measures and nutrition, hospitalization, and mortality in hemodialysis. J Am Soc Nephrol (2001) 2.28
Effect of food intake and fasting on gastrointestinal lead absorption in humans. Am J Clin Nutr (1980) 2.28
Parenteral nutrition is associated with intestinal morphologic and functional changes in humans. JPEN J Parenter Enteral Nutr (1996) 1.81
HDL-inflammatory index correlates with poor outcome in hemodialysis patients. Kidney Int (2007) 1.75
Phototaxis in Chlamydomonas reinhardtii. J Cell Biol (1973) 1.64
Kidney transplantation. A comparison of results using cadaver and related living donors. Am J Med (1969) 1.46
Relative contributions of nutrition and inflammation to clinical outcome in dialysis patients. Am J Kidney Dis (2001) 1.44
Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy. J Am Soc Nephrol (2001) 1.37
Oxidation of nicotinic acid by a Bacillus species: source of oxygen atoms for the hydroxylation of nicotinic acid and 6-hydroxynicotinic acid. J Bacteriol (1971) 1.29
Evidence that histidine is an essential amino acid in normal and chronically uremic man. J Clin Invest (1975) 1.28
Chemoresponses of Chlamydomonas reinhardtii. J Bacteriol (1978) 1.26
Nutritional management of maintenance dialysis patients: why aren't we doing better? Annu Rev Nutr (2001) 1.25
Oxidation of nicotinic acid by a Bacillus species: purification and properties of nicotinic acid and 6-hydroxynicotinic acid hydroxylases. J Bacteriol (1971) 1.23
Metabolic studies of low protein diets in uremia. II. Calcium, phosphorus and magnesium. Medicine (Baltimore) (1973) 1.21
Studies of human lead metabolism by use of stable isotope tracers. Environ Health Perspect (1974) 1.19
Methods for assessing nutritional status of patients with renal failure. Am J Clin Nutr (1980) 1.18
Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy. Kidney Int (2001) 1.16
Magnitude of lead intake from respiration by normal man. J Lab Clin Med (1977) 1.14
Nutritional assessment of continuous ambulatory peritoneal dialysis patients: an international study. Am J Kidney Dis (1991) 1.10
Amino acid transport systems. Nature (1984) 1.08
Proton exchange and internal motions in two chromomycin dimer-DNA oligomer complexes. Biochemistry (1991) 1.07
Recombinant human insulin-like growth factor-I accelerates recovery and reduces catabolism in rats with ischemic acute renal failure. J Clin Invest (1993) 1.07
Regulation of nitrogenase gene expression in anaerobic cultures of Anabaena variabilis. J Bacteriol (1988) 1.06
Proton exchange in DNA-luzopeptin and DNA-echinomycin bisintercalation complexes: rates and processes of base-pair opening. Biochemistry (1992) 1.06
Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy. Kidney Int (2000) 1.04
Nutritional requirement for taurine in patients receiving long-term parenteral nutrition. N Engl J Med (1985) 1.04
Protein losses during peritoneal dialysis. Kidney Int (1981) 1.03
Studies on nuclear and mitochondrial DNA of Saccharomyces cerevisiae. Cold Spring Harb Symp Quant Biol (1974) 1.02
Glucose absorption during continuous ambulatory peritoneal dialysis. Kidney Int (1981) 1.02
Selective screening for inborn errors of metabolism on clinical patients using tandem mass spectrometry in China: a four-year report. J Inherit Metab Dis (2007) 1.00
Amino acid losses during hemodialysis with infusion of amino acids and glucose. Kidney Int (1982) 1.00
Discrimination of Na+-independent transport systems L, T, and asc in erythrocytes. Na+ independence of the latter a consequence of cell maturation? J Biol Chem (1985) 1.00
Cross-sectional comparison of malnutrition in continuous ambulatory peritoneal dialysis and hemodialysis patients. Am J Kidney Dis (1995) 0.99
The hemodialysis pilot study: nutrition program and participant characteristics at baseline. The HEMO Study Group. J Ren Nutr (1998) 0.99
Metabolic balance studies and dietary protein requirements in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int (1982) 0.96
Evidence that insulin-like growth factor I increases renal plasma flow and glomerular filtration rate in fasted rats. J Clin Invest (1989) 0.95
NMR studies of exocyclic 1,N2-propanodeoxyguanosine adducts (X) opposite purines in DNA duplexes: protonated X(syn).A(anti) pairing (acidic pH) and X(syn).G(anti) pairing (neutral pH) at the lesion site. Biochemistry (1989) 0.95
Newer concepts of the indispensable amino acids. Am J Clin Nutr (1987) 0.95
Growth hormone, the insulin-like growth factor system, and the kidney. Endocr Rev (1996) 0.94
Protein metabolism in patients with chronic renal failure: role of uremia and dialysis. Kidney Int (2000) 0.93
Nutritional status and lymphocyte function in maintenance hemodialysis patients. Am J Clin Nutr (1984) 0.93
Effect of energy intake on nitrogen metabolism in nondialyzed patients with chronic renal failure. Kidney Int (1986) 0.93
Phototaxis mutants of Chlamydomonas reinhardtii. J Bacteriol (1977) 0.92
Arg169 is essential for catalytic activity of 3-hydroxybenzoate 6-hydroxylase from Klebsiella pneumoniae M5a1. Microbiol Res (2005) 0.92
Oxidation of nicotinic acid by a Bacillus species: regulation of nicotinic acid and 6-hydroxynicotinic acid hydroxylases. J Bacteriol (1972) 0.92
Effect of nitrogenous compounds on nitrogenase gene expression in anaerobic cultures of Anabaena variabilis. J Bacteriol (1988) 0.91
Effect of energy intake on nutritional status in maintenance hemodialysis patients. Kidney Int (1989) 0.91
Multicenter trial of L-carnitine in maintenance hemodialysis patients. II. Clinical and biochemical effects. Kidney Int (1990) 0.90
The taurine content of common foodstuffs. JPEN J Parenter Enteral Nutr (1990) 0.90
The delayed effect of growth hormone on renal function in humans. Kidney Int (1989) 0.90
Purification and characterization of Eikenella corrodens type IV pilin. Infect Immun (1995) 0.89
Effects of growth hormone and IGF-I on renal function. Kidney Int Suppl (1989) 0.89
Assessment of adherence to protein-restricted diets during conservative management of uremia. Am J Clin Nutr (1968) 0.89
Citrulline levels and urea cycle enzymes in uremic rats. J Nutr (1974) 0.89
Metabolic studies of low protein diets in uremia. I. Nitrogen and potassium. Medicine (Baltimore) (1973) 0.89
Identification and characterization of amino acid starvation-induced CD24 gene in MCF-7 human breast cancer cells. Int J Oncol (2000) 0.89
BRCA1 and BRCA2 gene mutation analysis: visit to the Breast Cancer Information Core (BIC). Oncol Res (1999) 0.89
Structure and regulation of genes encoding phycocyanin and allophycocyanin from Anabaena variabilis ATCC 29413. J Bacteriol (1988) 0.89
Effects of recombinant human insulin-like growth factor I on glomerular dynamics in the rat. J Clin Invest (1991) 0.88
Daily physical activity and physical function in adult maintenance hemodialysis patients. J Cachexia Sarcopenia Muscle (2014) 0.88
Fingernail creatinine as a predictor of prior renal function. Am J Kidney Dis (1993) 0.88
The free and bound amino acids removed by hemodialysis. Trans Am Soc Artif Intern Organs (1973) 0.88
Effects of insulin-like growth factor I on renal function in normal men. Kidney Int (1993) 0.88
Taurine concentrations in plasma and blood cells of patients undergoing long-term parenteral nutrition. Am J Clin Nutr (1986) 0.88
Chronic peritoneal dialysis for the management of chronic renal failure. Proc Clin Dial Transplant Forum (1973) 0.87
Dietary protein, urea nitrogen appearance and total nitrogen appearance in chronic renal failure and CAPD patients. Kidney Int (1997) 0.87
Insulin-like growth factor I induces mesangial proliferation and increases mRNA and secretion of collagen. Kidney Int (1995) 0.87
Visual function in patients undergoing long-term total parenteral nutrition. Am J Clin Nutr (1990) 0.86
Plasma amino acid levels and amino acid losses during continuous ambulatory peritoneal dialysis. Am J Clin Nutr (1982) 0.86
Amino acid metabolism in the chronically uremic rat. Clin Nephrol (1975) 0.86
Tail sectioning: a rapid and simple method for repeated blood sampling of the rat for corticosterone determination. Lab Anim Sci (1996) 0.86
Elevated myocardial cytosolic calcium impairs insulin-like growth factor-1-stimulated protein synthesis in chronic renal failure. J Am Soc Nephrol (1999) 0.86
Characteristics of taurine transport in rat liver lysosomes. J Cell Physiol (1991) 0.86
Plasmapheresis in the treatment of steroid-resistant focal segmental glomerulosclerosis in native kidneys. Am J Kidney Dis (1998) 0.86
Effect of blood pressure control and antihypertensive drug regimen on quality of life: the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Control Clin Trials (1996) 0.86
Daily requirement for pyridoxine supplements in chronic renal failure. Kidney Int (1981) 0.86
Glucagon and prostaglandins are mediators of amino acid-induced rise in renal hemodynamics. Kidney Int (1988) 0.85
Taurine concentrations in plasma, blood cells, and urine of children undergoing long-term total parenteral nutrition. Pediatr Res (1987) 0.85
Nutritional status of children undergoing continuous ambulatory peritoneal dialysis. Am J Clin Nutr (1983) 0.85
Effect of histidine intake of plasma and urine histidine levels, nitrogen balance and N tau-methylhistidine excretion in normal and chronically uremic men. J Nutr (1981) 0.85
Mutation analysis of BRCA1 gene in African-American patients with breast cancer. J Natl Med Assoc (2000) 0.85
Prognostic value of plasma HER-2/neu in African American and Hispanic women with breast cancer. Int J Oncol (1999) 0.85
Increase in renal plasma flow and glomerular filtration rate during growth hormone treatment may be mediated by insulin-like growth factor I. Am J Nephrol (1988) 0.84
Plasma and urine taurine levels in vegans. Am J Clin Nutr (1988) 0.84
Nutritional therapy in kidney failure. Nutr Rev (1981) 0.84
A low lymphocyte percentage is a predictor of mortality and hospitalization in hemodialysis patients. Clin Nephrol (2005) 0.84
Hyperglobulinemia may spuriously elevate measured serum inorganic phosphate levels. Am J Kidney Dis (1988) 0.84
Patterns of fasting plasma amino acid levels in chronic renal insufficiency: results from the feasibility phase of the Modification of Diet in Renal Disease Study. Am J Kidney Dis (1994) 0.84
Pregnancy outcome in gestational diabetes. Int J Gynaecol Obstet (2006) 0.84
Effect of protein intake on weight gain and plasma amino acid levels in uremic rats. Am J Physiol (1976) 0.83
Evidence that dog kidney is an endogenous source of histidine. Am J Physiol (1979) 0.83
Multicenter trial of L-carnitine in maintenance hemodialysis patients. I. Carnitine concentrations and lipid effects. Kidney Int (1990) 0.83